🇺🇸 FDA
Pipeline program

(Z)-endoxifen

ATOS-Z-201

Phase 2 small_molecule active

Quick answer

(Z)-endoxifen for Breast Neoplasms is a Phase 2 program (small_molecule) at ATOSSA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ATOSSA THERAPEUTICS, INC.
Indication
Breast Neoplasms
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials